journal article·2018-07Open access

Design of spherically structured 3D in vitro tumor models -Advances and prospects

L.P. Ferreira, V.M. Gaspar, J.F. Mano

Acta Biomaterialia· Volume 75

Abstract

Three-dimensional multicellular tumor models are receiving an ever-growing focus as preclinical drug-screening platforms due to their potential to recapitulate major physiological features of human tumors in vitro. In line with this momentum, the technologies for assembly of 3D microtumors are rapidly evolving towards a comprehensive inclusion of tumor microenvironment elements. Customized spherically structured platforms, including microparticles and microcapsules, provide a robust and scalable technology to imprint unique biomolecular tumor microenvironment hallmarks into 3D in vitro models. Herein, a comprehensive overview of novel advances on the integration of tumor-ECM components and biomechanical cues into 3D in vitro models assembled in spherical shaped platforms is provided. Future improvements regarding spatiotemporal/mechanical adaptability, and degradability, during microtumors in vitro 3D culture are also critically discussed considering the realistic potential of these platforms to mimic the dynamic tumor microenvironment. From a global perspective, the production of 3D multicellular spheroids with tumor ECM components included in spherical models will unlock their potential to be used in high-throughput screening of therapeutic compounds. It is envisioned, in a near future, that a combination of spherically structured 3D microtumor models with other advanced microfluidic technologies will properly recapitulate the flow dynamics of human tumors in vitro. Statement of significance The ability to correctly mimic the complexity of the tumor microenvironment in vitro is a key aspect for the development of evermore realistic in vitro models for drug-screening and fundamental cancer biology studies. In this regard, conventional spheroid-based 3D tumor models, combined with spherically structured biomaterials, opens the opportunity to precisely recapitulate complex cell-extracellular matrix interactions and tumor compartmentalization. This review provides an in-depth focus on current developments regarding spherically structured scaffolds engineered into in vitro 3D tumor models, and discusses future advances toward all-encompassing platforms that may provide an improved in vitro/in vivo correlation in a foreseeable future.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline10.1021/acsbiomaterials.5b00172 ↗
2. Drug development: raise standards for preclinical cancer research10.1038/483531a ↗
3. Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery10.1038/srep28951 ↗
4. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery10.1016/j.addr.2014.05.006 ↗
5. Heralding a new paradigm in 3D tumor modeling10.1016/j.biomaterials.2016.08.052 ↗
6. Spheroid-based drug screen: considerations and practical approach10.1038/nprot.2008.226 ↗
7. Imi Predect consortium, three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo10.1002/biot.201300492 ↗
8. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform10.3389/fbioe.2016.00012 ↗
9. Cell spheroids: the new frontiers in in vitro models for cancer drug validation10.1016/j.drudis.2016.06.024 ↗
10. Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM1010.1007/s00018-009-0089-0 ↗
11. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system10.1016/j.yexcr.2012.03.026 ↗
12. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma10.1038/sj.bjc.6604508 ↗
13. Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells10.1016/j.actbio.2016.06.014 ↗
14. The extracellular matrix modulates the hallmarks of cancer10.15252/embr.201439246 ↗
15. Microenvironmental regulation of therapeutic response in cancer10.1016/j.tcb.2014.11.006 ↗
16. Cell encapsulation via microtechnologies10.1016/j.biomaterials.2013.12.073 ↗
17. Engineering Cell Aggregates through Incorporated Polymeric Microparticles10.1016/j.actbio.2017.08.003 ↗
18. Semipermeable capsules wrapping a multifunctional and self-regulated co-culture microenvironment for osteogenic differentiation10.1038/srep21883 ↗
19. 25th anniversary article: designer hydrogels for cell cultures: a materials selection guide10.1002/adma.201302958 ↗
20. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained10.1038/srep19103 ↗
21. Interfacial geometry dictates cancer cell tumorigenicity10.1038/nmat4610 ↗
22. 3D tumor spheroids: an overview on the tools and techniques used for their analysis10.1016/j.biotechadv.2016.11.002 ↗
23. Wharton’s jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer10.1016/j.yexcr.2016.06.003 ↗
24. High and low molecular weight hyaluronic acid differentially influence macrophage activation10.1021/acsbiomaterials.5b00181 ↗
25. The role of myeloid cells in the promotion of tumour angiogenesis10.1038/nrc2444 ↗
26. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment10.1073/pnas.1406655111 ↗
27. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments10.1016/j.addr.2014.02.008 ↗
28. Bioengineering 3D environments for cancer models10.1016/j.addr.2014.06.004 ↗
29. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression10.1016/j.biomaterials.2015.11.030 ↗
30. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments10.1016/j.canlet.2007.03.012 ↗
31. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis10.1177/1087057106292763 ↗
32. A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids
33. Biomimetic miniaturized platform able to sustain arrays of liquid droplets for high-throughput combinatorial tests10.1002/adfm.201400503 ↗
34. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: Comparison of success rate and cell line features10.1158/0008-5472.CAN-06-0594 ↗
35. Three-dimensional cell culture: The missing link in drug discovery10.1016/j.drudis.2012.10.003 ↗
36. Spherical cancer models in tumor biology10.1016/j.neo.2014.12.004 ↗
37. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: Implications for cancer growth and metastasis10.1158/0008-5472.CAN-08-2492 ↗
38. Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas2, JNCI
39. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array10.1039/C0AN00609B ↗
40. Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening10.3389/fphys.2017.00605 ↗
41. M.F. Gencoglu, L.E. Barney, C.L. Hall, E.A. Brooks, A.D. Schwartz, D.C. Corbett, K.R. Stevens, S.R. Peyton, Comparative study of multicellular tumor spheroid formation methods and implications for drug screening, ACS Biomater. Sci. Eng. (2017) acsbiomaterials.7b00069. doi:10.1021/acsbiomaterials.7b00069.10.1021/acsbiomaterials.7b00069 ↗
42. Semiautomatic growth analysis of multicellular tumor spheroids10.1177/1087057111419501 ↗
43. Combinatorial on-chip study of miniaturized 3D porous scaffolds using a patterned superhydrophobic platform10.1002/smll.201201436 ↗
44. A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening10.1039/C4BM00411F ↗
45. Generation of multicellular tumor spheroids by the hanging-drop method10.1007/978-1-59745-443-8_8 ↗
46. Fibroblasts influence survival and therapeutic response in a 3D co-culture model10.1371/journal.pone.0127948 ↗
47. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs10.1038/nm.2379 ↗
48. An update to space biomedical research: Tissue engineering in microgravity bioreactors
49. N. Picollet-D’hahan, M.E. Dolega, L. Liguori, C. Marquette, S. Le Gac, X. Gidrol, D.K. Martin, A 3D toolbox to enhance physiological relevance of human tissue models, Trends Biotechnol. 34 (2016) 757–769. doi:10.1016/j.tibtech.2016.06.012.10.1016/j.tibtech.2016.06.012 ↗
50. Rotating-wall vessels, promising bioreactors for osteoblastic cell culture: Comparison with other 3D conditions10.1007/BF02523224 ↗
51. In vitro three-dimensional (3D) models in cancer research: an update10.1002/mc.21844 ↗
52. Tissue-engineered models of human tumors for cancer research10.1517/17460441.2015.1009442 ↗
53. A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids10.1371/journal.pone.0154610 ↗
54. Test system for trifunctional antibodies in 3D MCTS culture10.1177/1087057109341766 ↗
55. Ex-vivo dynamic 3-D culture of human tissues in the RCCSTM bioreactor allows the study of multiple myeloma biology and response to therapy10.1371/annotation/d7d8e0a7-aa3d-4620-98e5-c5a7bbf31dc8 ↗
56. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids10.1002/bit.24399 ↗
57. Superhydrophobic chips for cell spheroids high-throughput generation and drug screening10.1021/am5018607 ↗
58. Coculture of spheroids/2D cell layers using a miniaturized patterned platform as a versatile method to produce scaffold-free tissue engineering building blocks
59. The tumor microenvironment is a dominant force in multidrug resistance10.1016/j.drup.2012.01.006 ↗
60. The extracellular matrix in development and morphogenesis: a dynamic view10.1016/j.ydbio.2009.10.026 ↗
61. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells10.1186/s13058-017-0801-1 ↗
62. Hyaluronidases in cancer biology
63. A novel role of low molecular weight hyaluronan in breast cancer metastasis10.1096/fj.14-259978 ↗
64. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer10.3389/fimmu.2015.00201 ↗
65. New functions for the matrix metalloproteinases in cancer progression10.1038/nrc745 ↗
66. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs10.1016/j.biomaterials.2011.10.056 ↗
67. Photo-click living strategy for controlled, reversible exchange of biochemical ligands10.1002/adma.201304847 ↗
68. Aligned collagen is a prognostic signature for survival in human breast carcinoma10.1016/j.ajpath.2010.11.076 ↗
69. Cellular mechanotransduction: Stiffness does matter10.1038/nmat4094 ↗
70. 3D collagen alignment limits protrusions to enhance breast cancer cell persistence10.1016/j.bpj.2014.10.035 ↗
71. Development of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineering
72. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells10.1002/ijc.25781 ↗
73. A blank slate? Layer-by-layer deposition of hyaluronic acid and chitosan onto various surfaces10.1021/bm060044l ↗
74. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells10.1016/j.biomaterials.2009.07.054 ↗
75. Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model10.1098/rsif.2012.0564 ↗
76. Porous biocompatible three-dimensional scaffolds of cellulose microfiber/gelatin composites for cell culture10.1016/j.actbio.2009.12.036 ↗
77. Development of an ex vivo breast cancer lung colonization model utilizing a decellularized lung matrix10.1039/c5ib00157a ↗
78. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells
79. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening10.1007/s10544-010-9417-2 ↗
80. Potential effect of matrix stiffness on the enrichment of tumor initiating cells under three-dimensional culture conditions10.1016/j.yexcr.2014.07.036 ↗
81. Chitosan-based thermoreversible hydrogel as an in Vitro tumor microenvironment for testing breast cancer therapies10.1021/mp5002119 ↗
82. 3D porous chitosan-alginate scaffolds as an in vitro model for evaluating nanoparticle-mediated tumor targeting and gene delivery to prostate cancer10.1021/acs.biomac.5b01032 ↗
83. A non-mulberry silk fibroin protein based 3D in vitro tumor model for evaluation of anticancer drug activity10.1002/adfm.201200375 ↗
84. Engineered silk fibroin protein 3D matrices for in vitro tumor model10.1016/j.biomaterials.2010.11.052 ↗
85. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness10.1016/j.biomaterials.2012.06.012 ↗
86. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells10.1021/bm0492632 ↗
87. Modeling tumor microenvironments using custom-designed biomaterial scaffolds10.1016/j.coche.2016.01.012 ↗
88. A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells10.1038/leu.2010.300 ↗
89. Electrospinning PCL scaffolds manufacture for three-dimensional breast cancer cell culture10.3390/polym9080328 ↗
90. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement10.1073/pnas.0808932106 ↗
91. Three-dimensional in vitro tumor models for cancer research and drug evaluation10.1016/j.biotechadv.2014.07.009 ↗
92. Dependence of cancer cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-free resonant waveguide grating biosensor10.1038/srep04034 ↗
93. G. Maheshwari, G. Brown, D.a Lauffenburger, a Wells, L.G. Griffith, Cell adhesion and motility depend on nanoscale RGD clustering, J. Cell Sci. 113 (Pt 1) (2000) 1677–1686. doi:10.1083/jcb.144.5.1019.10.1242/jcs.113.10.1677 ↗
94. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres10.1016/j.biomaterials.2016.10.052 ↗
95. PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture10.1002/jbm.a.35899 ↗
96. Stress relaxing hyaluronic acid-collagen hydrogels promote cell spreading, fiber remodeling, and focal adhesion formation in 3D cell culture10.1016/j.biomaterials.2017.11.004 ↗
97. Pore size and LbL chitosan coating influence mesenchymal stem cell in vitro fibrosis and biomineralization in 3D porous poly(epsilon-caprolactone) scaffolds10.1002/jbm.a.35381 ↗
98. H.W.H.J.H.W. Lee, Y.-M. Kook, H.W.H.J.H.W. Lee, H. Park, W.-G. Koh, A three-dimensional co-culture of HepG2 spheroids and fibroblasts using double-layered fibrous scaffolds incorporated with hydrogel micropatterns, RSC Adv. 4 (2014) 61005–61011. doi:10.1039/C4RA12269K.10.1039/C4RA12269K ↗
99. 3D printing for the development of in vitro cancer models10.1016/j.cobme.2017.06.003 ↗
100. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform10.1002/biot.201000340 ↗